Autoantibodies to erythropoietin receptor and clinical outcomes in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of CREDENCE trial

Kidney International Reports(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要